About 400 reports

EU Healthcare Predictions and Outlook, 2020 Executive SummaryMarket ScopeGeographic SegmentationKey Questions This Study Will AnswerTop Predictions for the EU Healthcare Industry, 2020 Overview of the 2020 EU Healthcare MarketEU Healthcare Industry Forecast by Seg

  • Diagnostics
  • Healthcare
  • European Union
  • World
  • Market Size
  • HEALTHCARE INDUSTRY'S OPINION ON GDPR
  • Healthcare Specific GDPR Definitions

General Data Protection Regulation (GDPR) in the Healthcare Industry H## 2018 Implications for Healthcare GDHCHT## Thematic Report | July 2018 AGENDA ## ##.

  • Healthcare
  • Europe
  • European Union
  • GLOBALDATA'S DEFINITION OF PERSONALIZED/PRECISION MEDICINE

Healthcare TABLE OF CONTENTS (##/ ##) ##.

  • Healthcare
  • European Union
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • DATAMONITOR HEALTHCARE'S PRICE ASSUMPTIONS FOR SYMBICORT
  • DATAMONITOR HEALTHCARE'S PRICE ASSUMPTIONS FOR ARCAPTA

term=GLOW+##& rank=## [Accessed ## March 2016].

  • Healthcare
  • European Union
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc

Cyramza

8770 10000 7800

Cyramza ## OVERVIEW ## Drug Overview ## Product Profiles ## Cyramza : Hepatocellular carcinoma (HCC) ## Cyramza : Non-small cell lung cancer (NSCLC) ## Cyramza : Gastric cancer ## Cyramza : Colorectal cancer (CRC) ## Cyramza : Bladder cancer LIST OF FIGURES ## Figure ##: Datamonitor

  • Cancer
  • Healthcare
  • Hepatitis
  • Pathology
  • European Union

Stivarga

8770 10000 7800

Stivarga ## OVERVIEW ## Drug Overview ## Product Profiles ## Stivarga : Hepatocellular carcinoma (HCC) ## Stivarga : Colorectal cancer (CRC) LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Stivarga for HCC ## Figure ##: Datamonitor

  • Colorectal Cancer
  • Healthcare
  • Hepatitis
  • Pathology
  • European Union

Nexavar

8770 10000 7800

Nexavar ## OVERVIEW ## Drug Overview ## Product Profiles ## Nexavar : Hepatocellular carcinoma (HCC) ## Nexavar : Renal cell carcinoma (RCC) LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Nexavar for HCC ## Figure ##: Datamonitor

  • Healthcare
  • Hepatitis
  • Renal Cancer
  • European Union
  • United States

Imfinzi

8770 10000 7800

Imfinzi ## OVERVIEW ## Drug Overview ## Product Profiles ## Imfinzi : Hepatocellular carcinoma (HCC) ## Imfinzi : Non-small cell lung cancer (NSCLC) ## Imfinzi : Head and neck cancer ## Imfinzi : Bladder cancer LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessme

  • Healthcare
  • Hepatitis
  • Lung Cancer
  • European Union
  • Demand

Tivicay

8770 10000 7800

Tivicay CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Tivicay : HIV LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Truvada for HIV ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Truvada for HIV ## Figure ##: T

  • Healthcare
  • HIV AIDS
  • Therapy
  • European Union
  • United States

Dovato

8770 10000 7800

Dovato CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Dovato : HIV LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of fostemsavir for HIV ## Figure ##: Datamonitor Healthcare’s drug assessment summary of fostemsavir for HIV ## Figure

  • Healthcare
  • HIV AIDS
  • Therapy
  • European Union
  • United States

Complera

8770 10000 7800

Complera CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Complera : HIV LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Complera for HIV ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Complera for HIV ## F

  • Healthcare
  • HIV AIDS
  • Therapy
  • European Union
  • United States

Atripla

8770 10000 7800

Atripla CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Atripla : HIV LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Atripla for HIV ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Atripla for HIV ## Figure

  • Healthcare
  • HIV AIDS
  • Therapy
  • European Union
  • United States

Isentress

8770 10000 7800

Isentress CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Isentress : HIV LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Tivicay for HIV ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Tivicay for HIV ## Figure ##

  • Healthcare
  • HIV Antiviral
  • Therapy
  • European Union
  • United States

Genvoya

8770 10000 7800

Genvoya CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Genvoya : HIV LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Symtuza for HIV ## Figure ##: Symtuza sales for HIV across the US and five major EU markets, by country, 2018–## ## Figure

  • Healthcare
  • Hepatitis Treatment
  • Therapy
  • European Union
  • United States

Tecentriq

8770 10000 7800

PD-L## binds to programmed death-## (PD-##) co-inhibitory receptors which are expressed on the surface of T cells after T-cell activation.

  • Cancer
  • Healthcare
  • European Union
  • United States
  • Demand
  • Datamonitor Healthcare's drug assessment summary for Latuda in bipolar disorder
  • Datamonitor Healthcare's drug assessment summary for Latuda in bipolar disorder

BIBLIOGRAPHY Bipolar disorder Disease Coverage | Forecast: Bipolar Disorder DMKC## US ## ## ## ## ## ## ## ## ## ## -##. ##% Japan ## ## ## ## ## ## ## ## ## ## -##. ##% France ## ## ## ## ## ## ## ## ## ## -##. ##% Germany

  • Healthcare
  • European Union
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Johnson & Johnson

Keytruda

8770 10000 7800

The interaction between PD-## and its primary ligand, PD-L##, inhibits T-cell proliferation and survival, and induces apoptosis of tumor-specific T-cells.

  • Cancer
  • Healthcare
  • Pathology
  • European Union
  • Japan

Lenvima

8770 10000 7800

Lenvima ## OVERVIEW ## Drug Overview ## Product Profiles ## Lenvima : Hepatocellular carcinoma (HCC) ## Lenvima : Renal cell carcinoma (RCC) LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Lenvima for HCC ## Figure ##: Datamonitor

  • Healthcare
  • Hepatitis
  • Pathology
  • Renal Cancer
  • European Union

Opdivo

8770 10000 7800

PD-## and its ligands, PD-L## and PD-L##, are members of the cluster of differentiation ## and B## family.

  • Cancer
  • Healthcare
  • Pathology
  • European Union
  • United States

Cabometyx

8770 10000 7800

Cabometyx ## OVERVIEW ## Drug Overview ## Product Profiles ## Cabometyx : Hepatocellular carcinoma (HCC) ## Cabometyx : Renal cell carcinoma (RCC) LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Cabometyx for HCC ## Figure ##: Datamonitor

  • Healthcare
  • Hepatitis
  • Renal Cancer
  • European Union
  • Supply

leronlimab

8770 10000 7800

leronlimab CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## leronlimab : HIV LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Delstrigo for HIV ## Figure ##: Datamonitor Healthcare’s drug assessment summary of leronlimab for HIV ## Figu

  • Healthcare
  • HIV AIDS
  • Medical Biotechnology
  • European Union
  • United States

Juluca

8770 10000 7800

Juluca CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Juluca : HIV LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of cabotegravir/ rilpivirine for HIV ## Figure ##: Cabotegravir/ rilpivirine sales for HIV across the US and five major

  • Antiviral
  • Healthcare
  • Therapy
  • European Union
  • United States

##: Datamonitor Healthcare’s drug assessment summary of Abilify for depression ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Abilify for depression ## Figure ##: Abilify sales for depression across the US, Japan, and five major EU markets, by country, ##

  • Healthcare
  • Mental Health
  • Pathology
  • Psychotic Disorder
  • European Union

Cymbalta

8770 10000 7800

Cymbalta CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Cymbalta : Depression ## Cymbalta : Neuropathic pain LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Cymbalta for depression ## Figure ##: Datamonitor Healthcare’s dru

  • Chronic Pain
  • Depression
  • Healthcare
  • European Union
  • United States
  • WHY IS EU GPDR COMPLIANCE FOR IT SECURITY IN HEALTHCARE IMPORTANT?
  • IDC PLANSCAPE: EU GPDR COMPLIANCE FOR IT SECURITY IN HEALTHCARE

One of the shortcomings of the current EU legislation is that an exact definition of healthcare data is missing.

  • Cybersecurity
  • Health Care Provider
  • Health Services
  • Healthcare
  • European Union

Ublituximab

8770 10000 7800

##: Datamonitor Healthcare’s drug assessment summary of ublituximab for CLL ## Figure ##: Datamonitor Healthcare’s drug assessment summary of ublituximab for CLL ## Figure ##: Ublituximab sales for CLL in the US, 2017–## ## Figure ##: Ublituximab for follicular lymphoma – S

  • Cancer
  • Healthcare
  • Lymphoma
  • European Union
  • United States

Zanubrutinib

8770 10000 7800

Zanubrutinib CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## zanubrutinib : Chronic lymphocytic leukemia (CLL) ## zanubrutinib : NHL: Follicular lymphoma (FL) LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of zanubrutinib for CLL ## Figu

  • Cancer
  • Healthcare
  • Lymphoma
  • European Union
  • United States

Kymriah

8770 10000 7800

Kymriah CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Kymriah : Chronic lymphocytic leukemia (CLL) ## Kymriah : NHL: Follicular lymphoma (FL) ## Kymriah : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessm

  • Cancer
  • Healthcare
  • Lymphoma
  • Pathology
  • European Union

Finerenone

8770 10000 7800

Finerenone CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## finerenone : Diabetic nephropathy LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of finerenone for diabetic nephropathy ## Figure ##: Datamonitor Healthcare’s drug assess

  • Healthcare
  • Pathology
  • Type 2 Diabetes
  • European Union
  • Market Description

Invokana

8770 10000 7800

Invokana CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Invokana : Diabetic nephropathy ## Invokana : Diabetes type ## LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Invokana for diabetic nephropathy ## Figure ##: Datamonitor

  • Healthcare
  • Sodium-Glucose Co-Transporter 2 Inhibitor
  • Type 2 Diabetes
  • European Union
  • Demand